Products Categories
CAS No.: | 6577-41-9 |
---|---|
Name: | Oxapium iodide |
Molecular Structure: | |
Formula: | C22H34NO2 |
Molecular Weight: | 471.422 |
Synonyms: | 1-[(2-Cyclohexyl-2-phenyl-1,3-dioxolan-4-yl)methyl]-1-methylpiperidiniumiodide (7CI);Piperidinium,1-[(2-cyclohexyl-2-phenyl-1,3-dioxolan-4-yl)methyl]-1-methyl-, iodide(8CI,9CI);1-(2-Phenyl-2-cyclohexyl-1,3-dioxolan-4-ylmethyl)-1-methylpiperidinium iodide;ANC 113;Ciclonium iodide;Cyclonium iodide;Esperan;Oxapium iodide;SH 100; |
Safety: | Poison by subcutaneous, intravenous, and intraperitoneal routes. Moderately toxic by ingestion. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx and I−. |
PSA: | 18.46000 |
LogP: | 1.42840 |
IUPAC Name: 1-[(2-Cyclohexyl-2-phenyl-1,3-dioxolan-4-yl)methyl]-1-methylpiperidin-1-ium iodide
Synonyms of of Oxapii iodidum (CAS NO.6577-41-9): Cyclonium ; Oxapium iodide [INN:JAN] ; 1-((2-Cyclohexyl-2-phenyl-1,3-dioxolan-4-yl)methyl)-1-methylpiperidinium iodide ; 2-Cyclohexyl-2-phenyl-4-piperidinomethyl-dioxolane-1,3 methiodide ; ANC 113 ; Ciclonium iodide ; Cyclonium iodide ; Esperan ; Iodure d'oxapium ; Iodure d'oxapium [INN-French] ; Ioduro de oxapio ; Ioduro de oxapio [INN-Spanish] ; N-Methyl-N-(2-cyclohexyl-2-phenyl-1,3 dioxolan-4-yl-methyl)-piperidinium iodide ; Oxapii iodidum [INN-Latin] ; SH 100 ; UNII-682380CG4N ; Piperidinium, 1-((2-cyclohexyl-2-phenyl-1,3-dioxolan-4-yl)methyl)-1-methyl-, iodide
CAS NO: 6577-41-9
Classification Code: Drug / Therapeutic Agent ; Reproductive Effect
Molecular Formula: C22H34NO2
Molecular Weight: 344.5103
Molecular Structure:
H bond acceptors: 3
Freely Rotating Bonds: 4
Polar Surface Area of Oxapii iodidum (CAS NO.6577-41-9): 18.46 Å2
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | intravenous | 31mg/kg (31mg/kg) | Drugs in Japan Vol. 6, Pg. 864, 1982. | |
mouse | LD50 | intraperitoneal | 16mg/kg (16mg/kg) | AUTONOMIC NERVOUS SYSTEM: PARASYMPATHOLYTIC | Polish Journal of Pharmacology and Pharmacy. Vol. 30, Pg. 493, 1978. |
mouse | LD50 | intravenous | 6970ug/kg (6.97mg/kg) | LUNGS, THORAX, OR RESPIRATION: DYSPNEA | Gekkan Yakuji. Pharmaceuticals Monthly. Vol. 13, Pg. 78, 1971. |
mouse | LD50 | oral | 500mg/kg (500mg/kg) | United States Patent Document. Vol. #4457931, | |
mouse | LD50 | subcutaneous | 86mg/kg (86mg/kg) | United States Patent Document. Vol. #4457931, | |
rat | LD50 | intravenous | 13900ug/kg (13.9mg/kg) | Drugs in Japan Vol. 6, Pg. 864, 1982. | |
rat | LD50 | oral | 494mg/kg (494mg/kg) | Oyo Yakuri. Pharmacometrics. Vol. 4, Pg. 109, 1970. | |
rat | LD50 | subcutaneous | 244mg/kg (244mg/kg) | Drugs in Japan Vol. 6, Pg. 864, 1982. |
Poison by subcutaneous, intravenous, and intraperitoneal routes. Moderately toxic by ingestion. Experimental reproductive effects. When heated to decomposition it emits toxic fumes of NOx and I−.
Loss on drying: 0.5%
ASH: Less than 0.2%
Heavy Metals: Less than 20ppm
Purity of Oxapii iodidum (CAS NO.6577-41-9): 98.5%min
Storage of Oxapii iodidum (CAS NO.6577-41-9): Keeped in well-closed place
Packing of: 1Kg/aluminium barrel,5Kg/aluminium barrel